chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 0.3
Sex: M
Vaccine: DTAP, HEP, HIBV, IPV, PNC, RV5, DTAP, HEP, HIBV, IPV, PNC, RV5
Symptoms: Haematochezia, Intussusception, Vomiting projectile
Clinical narrative: This report was identified from a line listing obtained on request by the Company from the FDA under the Freedom of Information Act. A 12 week old male, with no relevant medical history reported, who on 15-FEB-2008 was vaccinated with the first dose of ROTATEQ, Lot # 658379/1388U, by mouth; PEDVAXHIB, Lot # 656518/0258U, intramuscular in the right leg; DAPTACEL, Lot # C2800AA, intramuscular into the left leg; RECOMBIVAX HB, Lot # 656876/0874U, intramuscular into the right leg; PREVNAR, Lot # B70145K, intramuscular into the right leg and poliovirus vaccine inactivated (unspecified) (manufacturer unknown), Lot # A0298, subcutaneously into the left leg. The patient had severe projectile vomiting 48 hours after receiving vaccine, had bloody stools 72 hours after receiving vaccination and was diagnosed with intussusception of the intestines 78 hours after receiving vaccination. 25-FEB-2008 records received for date of service 18-FEB-2008, on 19-FEB-2008 the patient was discharged. Diagnosis: intussusception. The patient presented to emergency department with projectile vomiting and inability to take orally and 2 episodes of bloody stools. The patient had fever of 101.0 degrees. The listing indicated that one or more of the events required hospitalization, were considered to be immediately life-threatening. The original reporting source was not provided. The VAERS ID # is 305116. Lot check result for # 658379/1388U: A standard lot check investigation was performed. All in-process quality checks for the lot number in question were satisfactory. In addition, an expanded lot check investigation was performed. The testing performed on the batch prior to release met all release specifications. The lot met the requirements of the center and was released. No further information is available.
Age: 0.3
Sex: M
Vaccine: DTAP, HEP, HIBV, IPV, PNC, RV5, DTAP, HEP, HIBV, IPV, PNC, RV5
Symptoms: Blood culture negative, Body temperature increased, Diagnostic procedure, Enema administration, Haematochezia
Clinical narrative: This report was identified from a line listing obtained on request by the Company from the FDA under the Freedom of Information Act. A 12 week old male, with no relevant medical history reported, who on 15-FEB-2008 was vaccinated with the first dose of ROTATEQ, Lot # 658379/1388U, by mouth; PEDVAXHIB, Lot # 656518/0258U, intramuscular in the right leg; DAPTACEL, Lot # C2800AA, intramuscular into the left leg; RECOMBIVAX HB, Lot # 656876/0874U, intramuscular into the right leg; PREVNAR, Lot # B70145K, intramuscular into the right leg and poliovirus vaccine inactivated (unspecified) (manufacturer unknown), Lot # A0298, subcutaneously into the left leg. The patient had severe projectile vomiting 48 hours after receiving vaccine, had bloody stools 72 hours after receiving vaccination and was diagnosed with intussusception of the intestines 78 hours after receiving vaccination. 25-FEB-2008 records received for date of service 18-FEB-2008, on 19-FEB-2008 the patient was discharged. Diagnosis: intussusception. The patient presented to emergency department with projectile vomiting and inability to take orally and 2 episodes of bloody stools. The patient had fever of 101.0 degrees. The listing indicated that one or more of the events required hospitalization, were considered to be immediately life-threatening. The original reporting source was not provided. The VAERS ID # is 305116. Lot check result for # 658379/1388U: A standard lot check investigation was performed. All in-process quality checks for the lot number in question were satisfactory. In addition, an expanded lot check investigation was performed. The testing performed on the batch prior to release met all release specifications. The lot met the requirements of the center and was released. No further information is available.
Age: 0.3
Sex: M
Vaccine: DTAP, HEP, HIBV, IPV, PNC, RV5, DTAP, HEP, HIBV, IPV, PNC, RV5
Symptoms: Inappropriate schedule of drug administration, Intussusception, Neutrophil count, Oral intake reduced, Pyrexia
Clinical narrative: This report was identified from a line listing obtained on request by the Company from the FDA under the Freedom of Information Act. A 12 week old male, with no relevant medical history reported, who on 15-FEB-2008 was vaccinated with the first dose of ROTATEQ, Lot # 658379/1388U, by mouth; PEDVAXHIB, Lot # 656518/0258U, intramuscular in the right leg; DAPTACEL, Lot # C2800AA, intramuscular into the left leg; RECOMBIVAX HB, Lot # 656876/0874U, intramuscular into the right leg; PREVNAR, Lot # B70145K, intramuscular into the right leg and poliovirus vaccine inactivated (unspecified) (manufacturer unknown), Lot # A0298, subcutaneously into the left leg. The patient had severe projectile vomiting 48 hours after receiving vaccine, had bloody stools 72 hours after receiving vaccination and was diagnosed with intussusception of the intestines 78 hours after receiving vaccination. 25-FEB-2008 records received for date of service 18-FEB-2008, on 19-FEB-2008 the patient was discharged. Diagnosis: intussusception. The patient presented to emergency department with projectile vomiting and inability to take orally and 2 episodes of bloody stools. The patient had fever of 101.0 degrees. The listing indicated that one or more of the events required hospitalization, were considered to be immediately life-threatening. The original reporting source was not provided. The VAERS ID # is 305116. Lot check result for # 658379/1388U: A standard lot check investigation was performed. All in-process quality checks for the lot number in question were satisfactory. In addition, an expanded lot check investigation was performed. The testing performed on the batch prior to release met all release specifications. The lot met the requirements of the center and was released. No further information is available.
Age: 0.3
Sex: M
Vaccine: DTAP, HEP, HIBV, IPV, PNC, RV5, DTAP, HEP, HIBV, IPV, PNC, RV5
Symptoms: Small intestinal obstruction, Urinary system X-ray, Vomiting projectile, X-ray abnormal
Clinical narrative: This report was identified from a line listing obtained on request by the Company from the FDA under the Freedom of Information Act. A 12 week old male, with no relevant medical history reported, who on 15-FEB-2008 was vaccinated with the first dose of ROTATEQ, Lot # 658379/1388U, by mouth; PEDVAXHIB, Lot # 656518/0258U, intramuscular in the right leg; DAPTACEL, Lot # C2800AA, intramuscular into the left leg; RECOMBIVAX HB, Lot # 656876/0874U, intramuscular into the right leg; PREVNAR, Lot # B70145K, intramuscular into the right leg and poliovirus vaccine inactivated (unspecified) (manufacturer unknown), Lot # A0298, subcutaneously into the left leg. The patient had severe projectile vomiting 48 hours after receiving vaccine, had bloody stools 72 hours after receiving vaccination and was diagnosed with intussusception of the intestines 78 hours after receiving vaccination. 25-FEB-2008 records received for date of service 18-FEB-2008, on 19-FEB-2008 the patient was discharged. Diagnosis: intussusception. The patient presented to emergency department with projectile vomiting and inability to take orally and 2 episodes of bloody stools. The patient had fever of 101.0 degrees. The listing indicated that one or more of the events required hospitalization, were considered to be immediately life-threatening. The original reporting source was not provided. The VAERS ID # is 305116. Lot check result for # 658379/1388U: A standard lot check investigation was performed. All in-process quality checks for the lot number in question were satisfactory. In addition, an expanded lot check investigation was performed. The testing performed on the batch prior to release met all release specifications. The lot met the requirements of the center and was released. No further information is available.
Age: 0.5
Sex: M
Vaccine: DTAPHEPBIP, PNC, RV5, DTAPHEPBIP, PNC, RV5
Symptoms: Dehydration, Diarrhoea haemorrhagic, Enema administration, Haematochezia, Intussusception
Clinical narrative: This report was identified from a line listing obtained on request by the Company from the FDA under the Freedom of Information Act. A 6 month old male with history of torticollis, who on 28-NOV-2007 was vaccinated with the third dose of ROTATEQ, Lot # 657666/1391U, by mouth; PEDIARIX, Lot # AC21B124DB, intramuscular into the left leg and PREVNAR, Lot # C45888, intramuscular into the right leg. On 12-MAR-2008, the patient's mother called the clinic, she reported that the baby started vomiting for 24 hours and just had a diarrhea stool that was bloody. She was instructed to bring him in to the clinic and arrived within the hour with more episodes of bloody stools. Intravenous fluids were administered for treatment of dehydration. Child was admitted to the hospital for treatment after being diagnosed with intussusception. Hydrostatic reduction attempts were made but unsuccessful. Child was then taken to surgery for manual reduction of the intussusception. In 02-MAY-2008 emergency department records received, presented to emergency department with on and off abdominal pain times 1 week, vomiting with bouts of crying. Diagnosis: Intussusception. The patient was transferred. In 02-JUN-2008 records received for date of services 12-MAR-2008 - 15-MAR-2008 - the patient was discharged. Diagnosis: Intussusception, status post manual reduction and incidental appendectomy. Gastrographin enema was performed. 24 hour period of emesis starting on 11-MAR-2008, became yellow green and developed intermittent colicky episodic abdominal pain with knees posterior to chest or stiffening. The patient developed listlessness. There was bright red blood in diaper. On 27-FEB-2008 fussy and x-ray of abdomen did not reveal foreign body. The listing indicated that one or more of the events required hospitalization and were considered to be immediately life-threatening. Lot check result for # 657666/1391U: A standard lot check investigation was performed. All in-process quality checks for the lot number in question were satisfactory. In addition, an expanded lot check investigation was performed. The testing performed on the batch prior to release met all release specifications. The lot met the requirements of the center and was released. The original reporting source was not provided. The VAERS ID # is 311224. No further information is available.
Age: 0.5
Sex: M
Vaccine: DTAPHEPBIP, PNC, RV5, DTAPHEPBIP, PNC, RV5
Symptoms: Surgery, Ultrasound abdomen abnormal, Vomiting
Clinical narrative: This report was identified from a line listing obtained on request by the Company from the FDA under the Freedom of Information Act. A 6 month old male with history of torticollis, who on 28-NOV-2007 was vaccinated with the third dose of ROTATEQ, Lot # 657666/1391U, by mouth; PEDIARIX, Lot # AC21B124DB, intramuscular into the left leg and PREVNAR, Lot # C45888, intramuscular into the right leg. On 12-MAR-2008, the patient's mother called the clinic, she reported that the baby started vomiting for 24 hours and just had a diarrhea stool that was bloody. She was instructed to bring him in to the clinic and arrived within the hour with more episodes of bloody stools. Intravenous fluids were administered for treatment of dehydration. Child was admitted to the hospital for treatment after being diagnosed with intussusception. Hydrostatic reduction attempts were made but unsuccessful. Child was then taken to surgery for manual reduction of the intussusception. In 02-MAY-2008 emergency department records received, presented to emergency department with on and off abdominal pain times 1 week, vomiting with bouts of crying. Diagnosis: Intussusception. The patient was transferred. In 02-JUN-2008 records received for date of services 12-MAR-2008 - 15-MAR-2008 - the patient was discharged. Diagnosis: Intussusception, status post manual reduction and incidental appendectomy. Gastrographin enema was performed. 24 hour period of emesis starting on 11-MAR-2008, became yellow green and developed intermittent colicky episodic abdominal pain with knees posterior to chest or stiffening. The patient developed listlessness. There was bright red blood in diaper. On 27-FEB-2008 fussy and x-ray of abdomen did not reveal foreign body. The listing indicated that one or more of the events required hospitalization and were considered to be immediately life-threatening. Lot check result for # 657666/1391U: A standard lot check investigation was performed. All in-process quality checks for the lot number in question were satisfactory. In addition, an expanded lot check investigation was performed. The testing performed on the batch prior to release met all release specifications. The lot met the requirements of the center and was released. The original reporting source was not provided. The VAERS ID # is 311224. No further information is available.
Age: 0.5
Sex: M
Vaccine: DTAPHEPBIP, PNC, RV5, DTAPHEPBIP, PNC, RV5
Symptoms: Abdominal pain, Appendicectomy, Barium enema abnormal, Crying, Dehydration
Clinical narrative: This report was identified from a line listing obtained on request by the Company from the FDA under the Freedom of Information Act. A 6 month old male with history of torticollis, who on 28-NOV-2007 was vaccinated with the third dose of ROTATEQ, Lot # 657666/1391U, by mouth; PEDIARIX, Lot # AC21B124DB, intramuscular into the left leg and PREVNAR, Lot # C45888, intramuscular into the right leg. On 12-MAR-2008, the patient's mother called the clinic, she reported that the baby started vomiting for 24 hours and just had a diarrhea stool that was bloody. She was instructed to bring him in to the clinic and arrived within the hour with more episodes of bloody stools. Intravenous fluids were administered for treatment of dehydration. Child was admitted to the hospital for treatment after being diagnosed with intussusception. Hydrostatic reduction attempts were made but unsuccessful. Child was then taken to surgery for manual reduction of the intussusception. In 02-MAY-2008 emergency department records received, presented to emergency department with on and off abdominal pain times 1 week, vomiting with bouts of crying. Diagnosis: Intussusception. The patient was transferred. In 02-JUN-2008 records received for date of services 12-MAR-2008 - 15-MAR-2008 - the patient was discharged. Diagnosis: Intussusception, status post manual reduction and incidental appendectomy. Gastrographin enema was performed. 24 hour period of emesis starting on 11-MAR-2008, became yellow green and developed intermittent colicky episodic abdominal pain with knees posterior to chest or stiffening. The patient developed listlessness. There was bright red blood in diaper. On 27-FEB-2008 fussy and x-ray of abdomen did not reveal foreign body. The listing indicated that one or more of the events required hospitalization and were considered to be immediately life-threatening. Lot check result for # 657666/1391U: A standard lot check investigation was performed. All in-process quality checks for the lot number in question were satisfactory. In addition, an expanded lot check investigation was performed. The testing performed on the batch prior to release met all release specifications. The lot met the requirements of the center and was released. The original reporting source was not provided. The VAERS ID # is 311224. No further information is available.
Age: 0.5
Sex: M
Vaccine: DTAPHEPBIP, PNC, RV5, DTAPHEPBIP, PNC, RV5
Symptoms: Diarrhoea haemorrhagic, Enema administration, Intussusception, Irritability, Listless
Clinical narrative: This report was identified from a line listing obtained on request by the Company from the FDA under the Freedom of Information Act. A 6 month old male with history of torticollis, who on 28-NOV-2007 was vaccinated with the third dose of ROTATEQ, Lot # 657666/1391U, by mouth; PEDIARIX, Lot # AC21B124DB, intramuscular into the left leg and PREVNAR, Lot # C45888, intramuscular into the right leg. On 12-MAR-2008, the patient's mother called the clinic, she reported that the baby started vomiting for 24 hours and just had a diarrhea stool that was bloody. She was instructed to bring him in to the clinic and arrived within the hour with more episodes of bloody stools. Intravenous fluids were administered for treatment of dehydration. Child was admitted to the hospital for treatment after being diagnosed with intussusception. Hydrostatic reduction attempts were made but unsuccessful. Child was then taken to surgery for manual reduction of the intussusception. In 02-MAY-2008 emergency department records received, presented to emergency department with on and off abdominal pain times 1 week, vomiting with bouts of crying. Diagnosis: Intussusception. The patient was transferred. In 02-JUN-2008 records received for date of services 12-MAR-2008 - 15-MAR-2008 - the patient was discharged. Diagnosis: Intussusception, status post manual reduction and incidental appendectomy. Gastrographin enema was performed. 24 hour period of emesis starting on 11-MAR-2008, became yellow green and developed intermittent colicky episodic abdominal pain with knees posterior to chest or stiffening. The patient developed listlessness. There was bright red blood in diaper. On 27-FEB-2008 fussy and x-ray of abdomen did not reveal foreign body. The listing indicated that one or more of the events required hospitalization and were considered to be immediately life-threatening. Lot check result for # 657666/1391U: A standard lot check investigation was performed. All in-process quality checks for the lot number in question were satisfactory. In addition, an expanded lot check investigation was performed. The testing performed on the batch prior to release met all release specifications. The lot met the requirements of the center and was released. The original reporting source was not provided. The VAERS ID # is 311224. No further information is available.
Age: 0.5
Sex: M
Vaccine: DTAPHEPBIP, PNC, RV5, DTAPHEPBIP, PNC, RV5
Symptoms: Musculoskeletal stiffness, Surgery, Ultrasound abdomen abnormal, Vomiting
Clinical narrative: This report was identified from a line listing obtained on request by the Company from the FDA under the Freedom of Information Act. A 6 month old male with history of torticollis, who on 28-NOV-2007 was vaccinated with the third dose of ROTATEQ, Lot # 657666/1391U, by mouth; PEDIARIX, Lot # AC21B124DB, intramuscular into the left leg and PREVNAR, Lot # C45888, intramuscular into the right leg. On 12-MAR-2008, the patient's mother called the clinic, she reported that the baby started vomiting for 24 hours and just had a diarrhea stool that was bloody. She was instructed to bring him in to the clinic and arrived within the hour with more episodes of bloody stools. Intravenous fluids were administered for treatment of dehydration. Child was admitted to the hospital for treatment after being diagnosed with intussusception. Hydrostatic reduction attempts were made but unsuccessful. Child was then taken to surgery for manual reduction of the intussusception. In 02-MAY-2008 emergency department records received, presented to emergency department with on and off abdominal pain times 1 week, vomiting with bouts of crying. Diagnosis: Intussusception. The patient was transferred. In 02-JUN-2008 records received for date of services 12-MAR-2008 - 15-MAR-2008 - the patient was discharged. Diagnosis: Intussusception, status post manual reduction and incidental appendectomy. Gastrographin enema was performed. 24 hour period of emesis starting on 11-MAR-2008, became yellow green and developed intermittent colicky episodic abdominal pain with knees posterior to chest or stiffening. The patient developed listlessness. There was bright red blood in diaper. On 27-FEB-2008 fussy and x-ray of abdomen did not reveal foreign body. The listing indicated that one or more of the events required hospitalization and were considered to be immediately life-threatening. Lot check result for # 657666/1391U: A standard lot check investigation was performed. All in-process quality checks for the lot number in question were satisfactory. In addition, an expanded lot check investigation was performed. The testing performed on the batch prior to release met all release specifications. The lot met the requirements of the center and was released. The original reporting source was not provided. The VAERS ID # is 311224. No further information is available.
Age: 10.0
Sex: M
Vaccine: VARCEL, VARCEL
Symptoms: Pallor, Throat irritation, Vomiting
Clinical narrative: Information has been received from a physician concerning a 10 year old male with no pre-existing allergies or medical conditions who on 17-JUL-2008 in the afternoon was vaccinated subcutaneously in left arm with the second dose VARIVAX (Oka/Merck) (LOT# 661443/0528X). Within seconds after the vaccination, the patient complained of itchy throat. The patient started vomiting, foaming in the mouth and very pale. The patient was rushed to the emergency room but was not hospitalized. The patient was given oxygen saturation 99% on room air, epinephrine 1:1000 0.3 subcutaneously one time and BENADRYL 25 mg orally. The patient was stable with clear breath sounds. The patient was transferred to another emergency room for observation. On the same day, the patient recovered from the events. Upon internal review, vomiting, foaming in the mouth, very pale and itchy throat were considered as other important medical event. Additional information is not expected.
Age: 10.0
Sex: M
Vaccine: VARCEL, VARCEL
Symptoms: Foaming at mouth, Immediate post-injection reaction, Pallor, Throat irritation, Vomiting
Clinical narrative: Information has been received from a physician concerning a 10 year old male with no pre-existing allergies or medical conditions who on 17-JUL-2008 in the afternoon was vaccinated subcutaneously in left arm with the second dose VARIVAX (Oka/Merck) (LOT# 661443/0528X). Within seconds after the vaccination, the patient complained of itchy throat. The patient started vomiting, foaming in the mouth and very pale. The patient was rushed to the emergency room but was not hospitalized. The patient was given oxygen saturation 99% on room air, epinephrine 1:1000 0.3 subcutaneously one time and BENADRYL 25 mg orally. The patient was stable with clear breath sounds. The patient was transferred to another emergency room for observation. On the same day, the patient recovered from the events. Upon internal review, vomiting, foaming in the mouth, very pale and itchy throat were considered as other important medical event. Additional information is not expected.
Age: 0.1
Sex: F
Vaccine: DTAP, HEP, HIBV, IPV, PNC, RV5, DTAP, HEP, HIBV, IPV, PNC, RV5
Symptoms: Enema administration, Haematochezia, Intussusception, Vomiting
Clinical narrative: This report was identified from a line listing obtained on request by the Company from the FDA under the Freedom of Information Act.  A one month female who on 14-JUL-2008 was vaccinated with ROTATEQ (lot no. 660679/0407X) by mouth, TRIPEDIA IM into the left leg, RECOMBIVAX HB (lot no. 659666/1884U) IM into the right leg, ACTHIB (lot no. UF373AB) IM into the right leg, IPOL (lot no. A12187) IM, into the left leg and PREVNAR (lot no. C65042).  On 02-SEP-2008 the patient experienced intussusception that was reduced by an air contrast enema that did not required surgery.  The patient also experienced vomiting and blood in stools and was hospitalized.  Intussusception vomiting and blood in stool were considered to be immediately life-threatening.  The original reporting source was not provided.  The VAERS ID# is 324159.  A standard lot check investigation was performed.  All in-process quality checks for the lot number 660679/0407X, were satisfactory.  In addition, an expanded lot check investigation was performed.  The testing performed on the batch prior to release met all release specifications.  The lot met the requirements of the center and was released.  A standard lot check investigation was performed.  All in-process quality checks for the lot number 659666/1884U, were satisfactory.  In addition, an expanded lot check investigation was performed.  The testing performed on the batch prior to release met all release specifications.  The lot met the requirements of the center and was released.  No further information is available.
Age: 70.0
Sex: M
Vaccine: FLUX, FLU3
Symptoms: Urticaria
Clinical narrative: Patient broke out in hives under arm pits, lower abdominal and groin area. Patient took Benadryl that evening for the itch. Patient's symptoms resolved.
Age: 70.0
Sex: M
Vaccine: FLUX, FLU3
Symptoms: Pruritus, Urticaria
Clinical narrative: Patient broke out in hives under arm pits, lower abdominal and groin area. Patient took Benadryl that evening for the itch. Patient's symptoms resolved.
Age: 65.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Amnesia, Asthenia, Blood glucose decreased, Blood test, Electrocardiogram
Clinical narrative: Around 4 hrs after receiving AFLURIA vaccine I felt dizzy. I had some memory loss. I felt anxious, tingling lips, tongue, and fingers. I called the pharmacist who told me to call my doctor. he wasn't in office. At their urging, I went to the Local Urgent Care. Got an EKG, CBC, chemistry blood test.  Urgent Care Dr. didn't believe it was reaction to the vaccine. Dr tough it might be sugar drop, I disagree. It never happened before or since.
Age: 65.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Amnesia, Anxiety, Dizziness, Electrocardiogram, Full blood count
Clinical narrative: Around 4 hrs after receiving AFLURIA vaccine I felt dizzy. I had some memory loss. I felt anxious, tingling lips, tongue, and fingers. I called the pharmacist who told me to call my doctor. he wasn't in office. At their urging, I went to the Local Urgent Care. Got an EKG, CBC, chemistry blood test.  Urgent Care Dr. didn't believe it was reaction to the vaccine. Dr tough it might be sugar drop, I disagree. It never happened before or since.
Age: 65.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Laboratory test, Paraesthesia, Paraesthesia oral
Clinical narrative: Around 4 hrs after receiving AFLURIA vaccine I felt dizzy. I had some memory loss. I felt anxious, tingling lips, tongue, and fingers. I called the pharmacist who told me to call my doctor. he wasn't in office. At their urging, I went to the Local Urgent Care. Got an EKG, CBC, chemistry blood test.  Urgent Care Dr. didn't believe it was reaction to the vaccine. Dr tough it might be sugar drop, I disagree. It never happened before or since.
Age: 24.0
Sex: M
Vaccine: SMALL
Symptoms: Activated partial thromboplastin time normal, Alanine aminotransferase increased, Anion gap normal, Aspartate aminotransferase increased, Basophil percentage increased
Clinical narrative: Papular vesicular lesions with blisters on face, torso, lower legs and ankles.  TX- Vancomycin, Benadryl, EPIPEN, Zantac, Lovenox, Hydroxyzine, Doxepin, Calamine, Refresh Celluvisc *GREEN*, Tylenol, Motrin, Eucerin.  2/18/09 Received medical records from reporter for 10/10-10/23/2008. FINAL DX: pustular exanthem & nonviral bullous pustulosis following smallpox vaccination; immune mediated reaction to smallpox vaccine. Records reveal patient experienced raised pruitic rash all over on 10/9/08.  Exam revealed papular vesicular lesions w/blisters on face, torso, LEs.  Derm eval.  Tx w/Vancomycin.  Improved, lesions crusted over & d/c back to station.
Age: 24.0
Sex: M
Vaccine: SMALL
Symptoms: Bilirubin conjugated abnormal, Blister, Blood albumin normal, Blood alkaline phosphatase normal, Blood calcium normal
Clinical narrative: Papular vesicular lesions with blisters on face, torso, lower legs and ankles.  TX- Vancomycin, Benadryl, EPIPEN, Zantac, Lovenox, Hydroxyzine, Doxepin, Calamine, Refresh Celluvisc *GREEN*, Tylenol, Motrin, Eucerin.  2/18/09 Received medical records from reporter for 10/10-10/23/2008. FINAL DX: pustular exanthem & nonviral bullous pustulosis following smallpox vaccination; immune mediated reaction to smallpox vaccine. Records reveal patient experienced raised pruitic rash all over on 10/9/08.  Exam revealed papular vesicular lesions w/blisters on face, torso, LEs.  Derm eval.  Tx w/Vancomycin.  Improved, lesions crusted over & d/c back to station.
Age: 24.0
Sex: M
Vaccine: SMALL
Symptoms: Blood chloride normal, Blood creatinine normal, Blood glucose normal, Blood immunoglobulin E, Blood immunoglobulin G normal
Clinical narrative: Papular vesicular lesions with blisters on face, torso, lower legs and ankles.  TX- Vancomycin, Benadryl, EPIPEN, Zantac, Lovenox, Hydroxyzine, Doxepin, Calamine, Refresh Celluvisc *GREEN*, Tylenol, Motrin, Eucerin.  2/18/09 Received medical records from reporter for 10/10-10/23/2008. FINAL DX: pustular exanthem & nonviral bullous pustulosis following smallpox vaccination; immune mediated reaction to smallpox vaccine. Records reveal patient experienced raised pruitic rash all over on 10/9/08.  Exam revealed papular vesicular lesions w/blisters on face, torso, LEs.  Derm eval.  Tx w/Vancomycin.  Improved, lesions crusted over & d/c back to station.
Age: 24.0
Sex: M
Vaccine: SMALL
Symptoms: Blood immunoglobulin M normal, Blood magnesium normal, Blood phosphorus normal, Blood potassium normal, Blood sodium normal
Clinical narrative: Papular vesicular lesions with blisters on face, torso, lower legs and ankles.  TX- Vancomycin, Benadryl, EPIPEN, Zantac, Lovenox, Hydroxyzine, Doxepin, Calamine, Refresh Celluvisc *GREEN*, Tylenol, Motrin, Eucerin.  2/18/09 Received medical records from reporter for 10/10-10/23/2008. FINAL DX: pustular exanthem & nonviral bullous pustulosis following smallpox vaccination; immune mediated reaction to smallpox vaccine. Records reveal patient experienced raised pruitic rash all over on 10/9/08.  Exam revealed papular vesicular lesions w/blisters on face, torso, LEs.  Derm eval.  Tx w/Vancomycin.  Improved, lesions crusted over & d/c back to station.
Age: 24.0
Sex: M
Vaccine: SMALL
Symptoms: Blood urea normal, C-reactive protein increased, Carbon dioxide normal, Complement factor C3, Complement factor C4 decreased
Clinical narrative: Papular vesicular lesions with blisters on face, torso, lower legs and ankles.  TX- Vancomycin, Benadryl, EPIPEN, Zantac, Lovenox, Hydroxyzine, Doxepin, Calamine, Refresh Celluvisc *GREEN*, Tylenol, Motrin, Eucerin.  2/18/09 Received medical records from reporter for 10/10-10/23/2008. FINAL DX: pustular exanthem & nonviral bullous pustulosis following smallpox vaccination; immune mediated reaction to smallpox vaccine. Records reveal patient experienced raised pruitic rash all over on 10/9/08.  Exam revealed papular vesicular lesions w/blisters on face, torso, LEs.  Derm eval.  Tx w/Vancomycin.  Improved, lesions crusted over & d/c back to station.
Age: 24.0
Sex: M
Vaccine: SMALL
Symptoms: Eosinophil percentage increased, Haematocrit normal, Haemoglobin normal, Lymphocyte percentage, Mean cell haemoglobin concentration normal
Clinical narrative: Papular vesicular lesions with blisters on face, torso, lower legs and ankles.  TX- Vancomycin, Benadryl, EPIPEN, Zantac, Lovenox, Hydroxyzine, Doxepin, Calamine, Refresh Celluvisc *GREEN*, Tylenol, Motrin, Eucerin.  2/18/09 Received medical records from reporter for 10/10-10/23/2008. FINAL DX: pustular exanthem & nonviral bullous pustulosis following smallpox vaccination; immune mediated reaction to smallpox vaccine. Records reveal patient experienced raised pruitic rash all over on 10/9/08.  Exam revealed papular vesicular lesions w/blisters on face, torso, LEs.  Derm eval.  Tx w/Vancomycin.  Improved, lesions crusted over & d/c back to station.
Age: 24.0
Sex: M
Vaccine: SMALL
Symptoms: Mean cell haemoglobin normal, Mean cell volume normal, Methicillin-resistant staphylococcal aureus test negative, Monocyte percentage increased, Neutrophil percentage decreased
Clinical narrative: Papular vesicular lesions with blisters on face, torso, lower legs and ankles.  TX- Vancomycin, Benadryl, EPIPEN, Zantac, Lovenox, Hydroxyzine, Doxepin, Calamine, Refresh Celluvisc *GREEN*, Tylenol, Motrin, Eucerin.  2/18/09 Received medical records from reporter for 10/10-10/23/2008. FINAL DX: pustular exanthem & nonviral bullous pustulosis following smallpox vaccination; immune mediated reaction to smallpox vaccine. Records reveal patient experienced raised pruitic rash all over on 10/9/08.  Exam revealed papular vesicular lesions w/blisters on face, torso, LEs.  Derm eval.  Tx w/Vancomycin.  Improved, lesions crusted over & d/c back to station.
Age: 24.0
Sex: M
Vaccine: SMALL
Symptoms: Platelet count normal, Protein total decreased, Prothrombin time normal, Prothrombin time ratio, Rash papular
Clinical narrative: Papular vesicular lesions with blisters on face, torso, lower legs and ankles.  TX- Vancomycin, Benadryl, EPIPEN, Zantac, Lovenox, Hydroxyzine, Doxepin, Calamine, Refresh Celluvisc *GREEN*, Tylenol, Motrin, Eucerin.  2/18/09 Received medical records from reporter for 10/10-10/23/2008. FINAL DX: pustular exanthem & nonviral bullous pustulosis following smallpox vaccination; immune mediated reaction to smallpox vaccine. Records reveal patient experienced raised pruitic rash all over on 10/9/08.  Exam revealed papular vesicular lesions w/blisters on face, torso, LEs.  Derm eval.  Tx w/Vancomycin.  Improved, lesions crusted over & d/c back to station.
Age: 24.0
Sex: M
Vaccine: SMALL
Symptoms: Red blood cell count normal, Red cell distribution width normal, White blood cell count normal
Clinical narrative: Papular vesicular lesions with blisters on face, torso, lower legs and ankles.  TX- Vancomycin, Benadryl, EPIPEN, Zantac, Lovenox, Hydroxyzine, Doxepin, Calamine, Refresh Celluvisc *GREEN*, Tylenol, Motrin, Eucerin.  2/18/09 Received medical records from reporter for 10/10-10/23/2008. FINAL DX: pustular exanthem & nonviral bullous pustulosis following smallpox vaccination; immune mediated reaction to smallpox vaccine. Records reveal patient experienced raised pruitic rash all over on 10/9/08.  Exam revealed papular vesicular lesions w/blisters on face, torso, LEs.  Derm eval.  Tx w/Vancomycin.  Improved, lesions crusted over & d/c back to station.
Age: 16.0
Sex: F
Vaccine: HEP, HEPA, HPV4, MNQ, HEP, HEPA, HPV4, MNQ
Symptoms: Arthralgia, Face injury, Immediate post-injection reaction, Joint swelling, Syncope
Clinical narrative: Patient fainted after receiving vaccines.  Patient was sitting and fell forward.  Hit nose on counter. THen patient was layed back with legs elevated.  Patient came to in approximately 15-20 seconds.  Patient immediately c/o left ankle pain but ambulated out of clinic.  Per mother, patient has swelling and aching in left ankle-starting later in the day.
Age: 16.0
Sex: F
Vaccine: HEP, HEPA, HPV4, MNQ, HEP, HEPA, HPV4, MNQ
Symptoms: Arthralgia, Face injury, Fall, Joint swelling, Syncope
Clinical narrative: Patient fainted after receiving vaccines.  Patient was sitting and fell forward.  Hit nose on counter. THen patient was layed back with legs elevated.  Patient came to in approximately 15-20 seconds.  Patient immediately c/o left ankle pain but ambulated out of clinic.  Per mother, patient has swelling and aching in left ankle-starting later in the day.
Age: 60.0
Sex: F
Vaccine: PPV
Symptoms: Influenza like illness, Injection site urticaria, Pain in extremity
Clinical narrative: Eve of 10/10...Slight flu like symptoms. 10/11 morn left upper sore/achy. Later that eve arm continued to be sore but about 7 welts were noted scattered near the injection site & under the axilla. No itching - I took 37 mgr BENARYL & two TYLENOL - Welts faded after that after 2 days.
Age: 1.0
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Rash generalised, Urticaria
Clinical narrative: A raised rash was verbally diagnosed as urticaria by 2 pediatricians. No fever, the rash "moved" around his body, from 6/16/05 through 6/20/05. Unsatisfactory doctors visit with son pediatrician, on 6/16/05. She claimed that it was not caused by the vaccines injected on 5/19/05. Doctors visit at the same clinic on 6/17/05. Urticaria confirmed and Benadryl prescribed to ease the discomfort caused by the rash. The rash totally disappeared on 6/21/05 - 6/22/05.
Sex: F
Vaccine: HPV4
Symptoms: Dizziness
Clinical narrative: Information has been received from a physician concerning a female who was vaccinated with GARDASIL. The patient developed dizziness after vaccination. On an unspecified date the patient recovered from dizziness. The patient sought medical attention. This is one of several reports from the same source. Additional information has been requested.
Sex: F
Vaccine: HPV4
Symptoms: Thrombosis
Clinical narrative: Information has been received from a school receptionist concerning her daughter who was vaccinated with GARDASIL. Subsequently the patient experienced blood clots. The outcome is unknown. No further information is available. The patient sought unspecified medical attention. Additional information is not expected.
Sex: F
Vaccine: HPV4
Symptoms: Oedema peripheral, Swelling
Clinical narrative: Information has been received from a physician concerning a female who on 17-AUG-2008 was vaccinated with her first and only dose of GARDASIL. There was no concomitant medication. Within the 3-6 days after the vaccination, which is in approximately 20-AUG-2008 -23-Aug-2008, the patient developed swelling in hands and chin. She recovered from swelling in hands and chin at the time of the report. The patient sought medical attention. Additional information has been requested.
Age: 18.0
Sex: F
Vaccine: HPV4
Symptoms: Headache
Clinical narrative: Information has been received from a nurse practitioner concerning an 18 year old female who in October 2007, was administered her third dose of vaccination with GARDASIL, 0.5ml, IM. "About one month later" the patient experienced chronic head aches. Subsequently the patient was treated with NEURONTIN and Ibuprofen. The patient's chronic head aches persisted. The patient sought medical at the nurse practitioner's office. Additional information has been requested.
Age: 32.0
Sex: M
Vaccine: ANTH
Symptoms: Injection site erythema, Injection site oedema, Injection site pain, Injection site swelling
Clinical narrative: SM developed redness, swelling pain at anthrax injection site in triceps within 1-2 hours of receiving his vaccine.  Symptoms: Edema at injection site 50-120mm.
Age: 54.0
Sex: F
Vaccine: FLU3
Symptoms: Ocular hyperaemia
Clinical narrative: Red eyes.
Age: 49.0
Sex: F
Vaccine: FLU3
Symptoms: Ocular hyperaemia
Clinical narrative: Red eyes.
Age: 52.0
Sex: F
Vaccine: FLU3
Symptoms: Ocular hyperaemia
Clinical narrative: Red eyes.
Age: 27.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect dose administered, Injection site erythema
Clinical narrative: Patient was inadvertently given 1ml of influenza vaccine instead of 0.5ml dose. Pt reported arm was red at injection site for a few days, but has now resolved.
Age: 59.0
Sex: F
Vaccine: FLU3
Symptoms: Ocular hyperaemia
Clinical narrative: Red eyes.
Age: 0.8
Sex: U
Vaccine: FLU3
Symptoms: Injection site urticaria, Urticaria
Clinical narrative: Urticaria (Torso & Extremities) starting near injection site - No Hx of egg or latex allergy rash resolving.
Age: 55.0
Sex: F
Vaccine: FLU3
Symptoms: Aphonia
Clinical narrative: Patient suddenly lost voice, called M.D. & was told to take BENADRYL lost voice over 5-10 minute period resolution 4 hrs. after BENADRYL.
Age: 62.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Patient presented at the pharmacy on October 23, 2008 complaining of some redness and swelling near injection site about 4 inches in length and 2 inches in width. The patient was advised to continue applying cold compresses to area and instructed by the RPH to use and OTC antihistamine. The area was marked placing for dots at each corner and the patient was informed that if the area continued to grow, to contact her physician or ER immediately. VAERS completed. Patient was advised if any further problems, either contact PCP or visit ER. Documentation added to person's allergy profile.
Age: 36.0
Sex: F
Vaccine: FLU3
Symptoms: Angioedema, Anxiety, Hyperhidrosis, Injection site reaction
Clinical narrative: Local reaction at injection site. Mild symptoms of anxiety angioedema, diaphoretic.
Age: 57.0
Sex: F
Vaccine: FLUN3
Symptoms: Inappropriate schedule of drug administration, Nasal mucosal disorder
Clinical narrative: Pt received Flumist and it is not indicated for her age. Patient had a few sores in her nose which promptly cleared up.
Age: 82.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Oedema peripheral
Clinical narrative: Patient's (R) arm swelled from below elbow up to shoulder. Swelling started a couple of hours after shot. Patient has been taking TYLENOL and putting heat on it.
Age: 43.0
Sex: F
Vaccine: FLU3
Symptoms: Urticaria
Clinical narrative: Hives on Lower Back (No temperature) BENARYL cream & BENADRYL tabs Hives would only resolve w/BENADRYL tabs, cream alone did not help completely.
Age: 12.0
Sex: F
Vaccine: FLUN3, HPV4, VARCEL
Symptoms: Asthenia, Dizziness, Dry mouth, Pallor, Photopsia
Clinical narrative: Feeling faint, pale skin color, dry mouth, seeing stars, feeling weak.
Age: 39.0
Sex: F
Vaccine: FLU3
Symptoms: Chest discomfort, Erythema, Eye discharge, Eye pain, Eye pruritus
Clinical narrative: Was given vaccine at 1:45PM T: 97.5. Began feeling wheezy/tight chest at 3PM. No SOB. Continued normal activities by 5PM eyes became extremely bloodshot itchy, painful and very mucous filled. When I pressed on top or bottom of eyes copious amounts of yellow mucous. Eyes continued to be painful, swollen and red. Nose became red and productive cough developed. Took 25mg BENADRYL. Symptoms became manageable. That night had 1 episode of n & vomiting and achy. Next day woke feeling better and no signs and symptoms. Was if it never happened.
Age: 39.0
Sex: F
Vaccine: FLU3
Symptoms: Eye swelling, Ocular hyperaemia, Pain, Productive cough, Vomiting
Clinical narrative: Was given vaccine at 1:45PM T: 97.5. Began feeling wheezy/tight chest at 3PM. No SOB. Continued normal activities by 5PM eyes became extremely bloodshot itchy, painful and very mucous filled. When I pressed on top or bottom of eyes copious amounts of yellow mucous. Eyes continued to be painful, swollen and red. Nose became red and productive cough developed. Took 25mg BENADRYL. Symptoms became manageable. That night had 1 episode of n & vomiting and achy. Next day woke feeling better and no signs and symptoms. Was if it never happened.
Age: 39.0
Sex: F
Vaccine: FLU3
Symptoms: Wheezing
Clinical narrative: Was given vaccine at 1:45PM T: 97.5. Began feeling wheezy/tight chest at 3PM. No SOB. Continued normal activities by 5PM eyes became extremely bloodshot itchy, painful and very mucous filled. When I pressed on top or bottom of eyes copious amounts of yellow mucous. Eyes continued to be painful, swollen and red. Nose became red and productive cough developed. Took 25mg BENADRYL. Symptoms became manageable. That night had 1 episode of n & vomiting and achy. Next day woke feeling better and no signs and symptoms. Was if it never happened.
Age: 16.0
Sex: F
Vaccine: HPV4
Symptoms: Hypersensitivity, Hypoaesthesia, No reaction on previous exposure to drug, Pharyngeal oedema, Rash
Clinical narrative: Child received GARASIL #2 on 10-21-08 - 2pm. Mom gave Vit D p.o 9pm 10-21-08 - Started with skins rash, numbness, throat swelling. Treated at ED after syms started. IV steroid given with EPI-PEN. Dr at ED voiced felt it was allergic reaction to vit D, not GARDASIL. No reaction previous GARDASIL given 7-22-08.
Age: 53.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Blister, Erythema, Swelling
Clinical narrative: Redness, swelling and blisters.
Age: 32.0
Sex: F
Vaccine: FLU3
Symptoms: Dizziness, Dysgeusia, Hypoaesthesia, Hypoaesthesia oral, Nausea
Clinical narrative: Dizzy, strong smell of medicine/metal, nausea, numbness hands, fingertips & lips.
Age: 32.0
Sex: F
Vaccine: FLU3
Symptoms: Parosmia, Urticaria
Clinical narrative: Dizzy, strong smell of medicine/metal, nausea, numbness hands, fingertips & lips.
Age: 18.0
Sex: F
Vaccine: MMR, TDAP
Symptoms: Dizziness, Headache, Oropharyngeal pain, Pyrexia, Streptococcal identification test negative
Clinical narrative: Fever of 102-103 started 24 hours after vaccine. Also had dizziness, headache & sore throat, that was relieved by ADVIL but kept coming back. She went to the doctor on 10-21-08 - 4 days post vaccine when symptoms persisted. She was also not responding with reduction of fever after ADVIL on 10-21-08.
Age: 47.0
Sex: M
Vaccine: FLU3
Symptoms: Cough, Hyperhidrosis, Hypertension, Pain, Petechiae
Clinical narrative: Diaphoretic, body aches, dry cough, low grade fever. Petechiae bilaterally lower legs and to po & feet. HTN.
Age: 47.0
Sex: M
Vaccine: FLU3
Symptoms: Pyrexia
Clinical narrative: Diaphoretic, body aches, dry cough, low grade fever. Petechiae bilaterally lower legs and to po & feet. HTN.
Age: 42.0
Sex: F
Vaccine: FLU3
Symptoms: Anxiety, Dyspnoea, Influenza like illness, Injection site irritation, Palpitations
Clinical narrative: Flu shot 10-23-08 0800. By noon wheezing, anxious SOB, heart racing. 3PM Flu-like achy & burning at inject. site - Reports no redness, swelling or heat at site. 1st Flu shot ever. Full recovery by Mon.
Age: 42.0
Sex: F
Vaccine: FLU3
Symptoms: Wheezing
Clinical narrative: Flu shot 10-23-08 0800. By noon wheezing, anxious SOB, heart racing. 3PM Flu-like achy & burning at inject. site - Reports no redness, swelling or heat at site. 1st Flu shot ever. Full recovery by Mon.
Age: 58.0
Sex: F
Vaccine: FLU3
Symptoms: Abdominal pain upper, Asthenia, Body temperature increased, Chills, Feeling hot
Clinical narrative: 1hr after shot felt hot & nauseous progressing to 102 F, body aches, stomach ache, chills, weak. Weak next day & then fine.
Age: 58.0
Sex: F
Vaccine: FLU3
Symptoms: Nausea, Pain
Clinical narrative: 1hr after shot felt hot & nauseous progressing to 102 F, body aches, stomach ache, chills, weak. Weak next day & then fine.
Age: 48.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site erythema, Injection site induration
Clinical narrative: 4" x 4" reddened hard area around admin site without        streaking, lymphadenopathy, or fever.
Age: 45.0
Sex: F
Vaccine: FLUX
Symptoms: Asthenia, Chills, Dyspnoea, Headache, Myalgia
Clinical narrative: A couple of hours after shot - difficulty breathing, paleness, chills, weakness, headache, sore muscles, symptoms lasted about a day + 1/2.
Age: 45.0
Sex: F
Vaccine: FLUX
Symptoms: Pallor
Clinical narrative: A couple of hours after shot - difficulty breathing, paleness, chills, weakness, headache, sore muscles, symptoms lasted about a day + 1/2.
Age: 47.0
Sex: F
Vaccine: FLUX
Symptoms: Blood test, Cough, Dysphonia, Eye swelling, Heart rate increased
Clinical narrative: Fever, hoarseness, coughing, swelling of the eyes + throat, fast hart beat.
Age: 47.0
Sex: F
Vaccine: FLUX
Symptoms: Pharyngeal oedema, Pyrexia
Clinical narrative: Fever, hoarseness, coughing, swelling of the eyes + throat, fast hart beat.
Age: 39.0
Sex: F
Vaccine: FLU3
Symptoms: Food allergy, Hypersensitivity, Lip swelling, Rash
Clinical narrative: Immunized 10/17/08 at Health Fair after 1/2 she had rash on legs/arms/chest and lips swelled. No medical eval. Pt was a nurse who took BENADRYL every 6  Without further problems previously received flu shot without problem. Reports Increasing general hypersensitivity over the last few years.
Age: 49.0
Sex: F
Vaccine: FLU3
Symptoms: Auricular swelling, Urticaria
Clinical narrative: Pt developed hives going up the arm and neck- stated swelling of left ear, patient called facility on 10/23/08 and took Claritin 10mg after that no more hives, swelling, etc. Stated had same reaction with PCN and Sulfa.
Age: 29.0
Sex: F
Vaccine: FLU3
Symptoms: Dry mouth, Palpitations, Speech disorder, Trismus
Clinical narrative: Racing heart clenching jaw difficulty speaking dry mouth The patient was given BENADRYL Oral Capsule 25mg by mouth now and every 6 hrs as needed symptoms children TYLENOL chewable 80mg 4 by mouth.